PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAcrivon Therapeutics
Acrivon Therapeutics(ACRV)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Bevifimod
uveal neoplasms
,
neoplasms
,
melanoma
PREXASERTIB
neoplasms
,
colorectal neoplasms
,
neoplasm metastasis
,
non-small-cell lung carcinoma
,
recurrence
,
brain neoplasms
,
central nervous system neoplasms
,
medulloblastoma
,
head and neck neoplasms
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
myeloid leukemia
,
preleukemia
,
syndrome
,
carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
squamous cell neoplasms
,
second primary neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
lung neoplasms
,
small cell lung carcinoma
Arm1
neoplasms
,
carcinoma
,
colorectal neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
melanoma
,
adenocarcinoma
,
papillary thyroid cancer
,
astrocytoma
,
acinar cell carcinoma
,
mutation rate
,
glioma
Arm2
pancreatic neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use